另外，本发明还提供了包含将单链负链rna病毒和药学上可容许的承运体混合的步骤的抗癌剂的制备方法。
Furthermore, the present invention provides methods for producing the anticancer agents, which comprise the step of mixing a minus-strand RNA virus with pharmaceutically acceptable carriers.
另外，本发明还提供了包含将单链负链rna病毒和药学上可容许的承运体混合的步骤的抗癌剂的制备方法。
Furthermore, the present invention provides methods for producing the anticancer agents, which comprise the step of mixing a minus-strand RNA virus with pharmaceutically acceptable carriers.
应用推荐